Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. van der Vorm (Apeldoorn, Netherlands), L. Li (Maastricht, Netherlands), D. Huskens (Maastricht, Netherlands), J. Hulstein (Apeldoorn, Netherlands), M. Roest (Maastricht, Netherlands), P. De Groot (Maastricht, Netherlands), H. Ten Cate (Maastricht, Netherlands), B. De Laat (Maastricht, Netherlands), J. Remijn (Apeldoorn, Netherlands), S. Simons (Maastricht, Netherlands). Acute exacerbations of COPD induce a prothrombotic state through platelet-monocyte complexes, endothelial activation and increased thrombin generation. 1069

Member's Comments

No comment yet.

Related content which might interest you: Platelet activation is enhanced in stable and exacerbated COPD Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 Increased circulating endothelial microparticles in COPD Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Elevated Von Willebrand Factor expression in the activated pulmonary endothelium of chronic thromboembolic pulmonary hypertension patients enhances platelet adhesion. Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020 Platelet depletion abolishes neutrophil recruitment in non-allergic murine models of acute inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 760s Year: 2006 Neutrophil airway influx by platelet-activating factor in asthma: role of adhesion molecules and LTB4 expression Source: Eur Respir J 2003; 22: 290-297 Year: 2003 Increased levels of circulating endothelial progenitor cells during exacerbations of COPD Source: Annual Congress 2007 - Biomarkers and assessment of COPD Year: 2007 Effect of acute exacerbations on circulating thrombotic and fibrinolytic markers in COPD patients Source: Annual Congress 2011 - COPD exacerbation Year: 2011 The role of complement activation in COPD exacerbation recovery Source: ERJ Open Res, 2 (4) 00027-2016; 10.1183/23120541.00027-2016 Year: 2016 Effects of chronic nitric oxide inhibition on eosinophil recruitment and extracellular matrix remodelling in chronic pulmonary inflammation Source: Eur Respir J 2007; 30: Suppl. 51, 735s Year: 2007 Neutrophil apoptosis and systemic inflammatory markers in acute exacerbation of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 572s Year: 2003 Oxidative stress-induced corticosteroid insensitivity is reversed by formoterol via inhibition of PI3K signalling in peripheral blood mononuclear cells from patients with COPD and severe asthma Source: Annual Congress 2011 - Models of disease and drug actions Year: 2011 Angiopoietin-1 inhibits endothelial permeability and neutrophil adherence induced by H2O2 or thrombin Source: Eur Respir J 2002; 20: Suppl. 38, 228s Year: 2002 Regulation of inflammation process in chronic thromboembolic pulmonary hypertension: a potential role of platelet-activating factor-acetylhydrolase Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling Year: 2006 HIV-associated pulmonary arterial hypertension onset is associated with the soluble CD14 level and inflammation related to monocyte activation by LPS translocation from the gut Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 Circulating fibrocyte recruitment and differentiation inhibited by treprostinil in pulmonary hypertension murine model Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Altered expression of adhesion molecules in circulating neutrophils of patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 479s Year: 2002 Effects of a neutrophil elastase inhibitor against mediators of acute exacerbation of pulmonary fibrosis: a new therapeutic strategy Source: Annual Congress 2008 - New therapeutic strategies in idiopathic pulmonary fibrosis Year: 2008 Inflammatory mediators CRP, fibrinogen and leukocyte in stable COPD patients Source: Annual Congress 2007 - Airway regulation, provocation and monitoring I Year: 2007 Antifibrotics modulate B lymphocyte activation resulting in a decrease of the profibrotic milieu in patients with pulmonary fibrosis Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019 RAGE-dependent VCAM-1 expression in the pulmonary endothelium mediates IL-33 induced asthma pathogenesis Source: International Congress 2017 – Therapeutic approaches in lung disease Year: 2017